Bio-Rad updates Sartorius AG 2025 financials: sales €3.54B, net profit €230M

BIO-RAD LABORATORIES, INC.

Sartorius AG 2025: sales €3,538.1M, gross profit €1,636.7M, EBIT €542.6M, net profit €230.4M.
Balance sheet: current assets €1,766.2M, non-current €7,951.1M, total equity €3,867.2M.
Operating cash flow €837.0M; investing outflow €513.7M; financing outflow €591.4M.
Update follows Sartorius’ Feb 16, 2026 release; Bio-Rad’s 10-K investment disclosure updated accordingly.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.